{"skill":{"slug":"biomarin","displayName":"Biomarin","summary":"BioMarin specializes in rare genetic metabolic diseases with enzyme replacement and gene therapies, holding multiple orphan drug approvals globally.","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":99,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1778234727455,"updatedAt":1778492876503},"latestVersion":{"version":"1.0.0","createdAt":1778234727455,"changelog":"BioMarin Pharmaceutical 1.0.0 — 初始版本发布\n\n- 简要介绍公司历史和里程碑，包括成立、上市、核心产品批准及最新财务表现\n- 概述核心业务结构：酶替代疗法、小分子药物、基因治疗\n- 总结公司在罕见病领域的竞争优势\n- 量化关键指标，如营收、上市药物数量和研发投入比例\n- 补充罕见病药物定价与业务模式说明，强化行业理解","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}